The Landscape of Cell and Gene Therapies for Solid Tumors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Landscape of Cell and Gene Therapies for Solid Tumors

Published:2021-01 Issue:1 Volume:39 Page:7-8
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Wang Shuhang,Sun Fa,Huang Huiyao,Chen Kun,Li Qi-Jing,Zhang Lu,Wang Enxiu,Wang Chen,Zhang Hai,Yuan Andy Qingan,Chen Bin,Deng Tao,Liu Yarong,Sun Jingwei,Liu Dongfang,Yu Yue,Fang Yuan,Jiang Ning,Wu Dawei,Fang Hong,Bai Ying,Xing Shujun,Ni Yufen,Fan Qi,Yu Anqi,Sun Chao,Tang Yu,Li Ning,Xu Binghe,He Jie

Funder

Beijing Municipal Science and Technology Commission

Chinese Academy of Medical Sciences

National Health Commission of the People's Republic of China

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference5 articles.

1. Engineering CAR-T cells for next-generation cancer therapy;Hong;Cancer Cell,2020

2. Identifying and targeting human tumor antigens for T cell-based immunotherapy of solid tumors;Leko;Cancer Cell,2020

3. CRISPR-engineered T cells in patients with refractory cancer;Stadtmauer;Science,2020

4. New directions in cellular therapy of cancer: a summary of the summit on cellular therapy for cancer;Stroncek;J. Transl. Med.,2012

5. Cytotoxic T lymphocyte migration and effector function in the tumor microenvironment;Weigelin;Immunol. Lett.,2011

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serum EZH2 is a novel biomarker for bladder cancer diagnosis and prognosis;Frontiers in Oncology;2024-02-27

2. Adoptive T Cell Therapy in Solid Tumors: State-of-the Art, Current Challenges, and Upcoming Improvements;Molecular Cancer Therapeutics;2024-01-18

3. Nanotechnology‐based CRISPR/Cas9 delivery system for genome editing in cancer treatment;MedComm – Biomaterials and Applications;2024-01-14

4. DNA-Based Nonviral Gene Therapy─Challenging but Promising;Molecular Pharmaceutics;2024-01-10

5. 3D sponge loaded with cisplatin–CS–calcium alginate MPs utilized as a void-filling prosthesis for the efficient postoperative prevention of tumor recurrence and metastasis;RSC Advances;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3